Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis

Introduction

This report analyzes the global biotechnology market in terms of market size (reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding), key drivers and resistors, trends and competitive positioning. It includes profiles of the top ten companies in the industry along with 5-year financial analysis and in-depth SWOT analysis.

Scope

*Performance of the global biotechnology market on the basis of sales, volume and respective growth patterns over the past five years

*Obtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the last 12 months

*Analysis of the Strengths, Weaknesses, Opportunities and Threats of the top 10 biotechnology companies along with business overview and financials

*Benchmark the performance of the top 10 players for the past five years; includes revenue comparison, profitability analysis, industry-specific ratios

Highlights

The global biotechnology market grew by 10.6% in 2007 to reach a value of $171,803 million.

In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.

In value terms, the medical/healthcare segment generated 69.4% of the global biotechnology market value.

Reasons to Purchase

*Save time, money and resources on analyzing the top 10 biotechnology companies using this report

*Analyze the global biotechnology market with key industry metrics including market value, market volume, and growth forecasts

*Assess the intensity of competition based on the 5-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power


Report Highlights
The global biotechnology market grew by 10.6% in 2007 to reach a value of $171,803 million.

In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.<
[Cerrar las informaciones del articulo de mercado]

Table of Contents 2
FIGURES 3
Tables 4
Executive Summary 5
Industry analysis 5
Industry definition 5
Research highlights 5
Top 10 companies landscape 6
Top 10 companies landscape 6
Market Value 7
Market Forecast 8
Market Segmentation-Product 9
Market Segmentation-Geographic 10
Five Forces Analysis 11
Summary 11
Buyer power 12
Supplier power 13
New entrants 14
Substitutes 15
Rivalry 16
Top 10 Companies Landscape 17
Top 10 Companies Landscape 17
Amgen 18
Genentech 18
Gilead Sciences 19
UCB 19
Genzyme 19
Biogen Idec 19
CSL 19
Celgene 19
Cephalon 20
Actelion 20
Revenue analysis 21
Financial performance analysis 23
Operating profit analysis 24
Net profit analysis 25
Ratio analysis 26
Company Reports 28
Amgen 28
Company overview 28
Business description 28
SWOT analysis 29
Strengths 29
Weaknesses 29
Opportunities 30
Threats 31
Recent developments 32
Genentech 33
Company overview 33
Business description 33
SWOT analysis 34
Strengths 34
Weaknesses 35
Opportunities 36
Threats 37
Recent developments 37
Gilead Sciences 38
Company overview 38
Business description 38
SWOT analysis 39
Strengths 39
Weaknesses 39
Opportunities 39
Threats 40
Recent developments 41
UCB 42
Company overview 42
Business description 42
SWOT analysis 43
Strengths 43
Weaknesses 44
Opportunities 44
Threats 45
Recent developments 45
Genzyme 47
Company overview 47
Business description 47
SWOT analysis 48
Strengths 48
Weaknesses 49
Opportunities 49
Threats 50
Recent developments 50
Biogen Idec 52
Company overview 52
Business description 52
SWOT analysis 53
Strengths 53
Weaknesses 53
Opportunities 54
Threats 54
Recent developments 55
CSL 56
Company overview 56
Business description 56
SWOT analysis 57
Strengths 57
Weaknesses 58
Opportunities 58
Threats 59
Recent developments 60
Celgene 61
Company overview 61
Business description 61
SWOT analysis 61
Strengths 61
Weaknesses 62
Opportunities 62
Threats 63
Recent developments 64
Cephalon 65
Company overview 65
Business description 65
SWOT analysis 66
Strengths 66
Weaknesses 66
Opportunities 66
Threats 67
Recent developments 68
Actelion 69
Company overview 69
Business description 69
SWOT analysis 70
Strengths 70
Weaknesses 70
Opportunities 71
Threats 72
Recent developments 72
Financial Analysis 73
Amgen 73
Genentech 76
Gilead Sciences 79
UCB 82
Genzyme 85
Biogen Idec 88
CSL 91
Celgene 94
Cephalon 97
Actelion 100
Appendix 103
List of Tables
Table 1: Global biotechnology market, $ million, 2003-07 7
Table 2: Global biotechnology market forecast, $ million, 2007-12 8
Table 3: Global biotechnology market segmentation-product , % share, 2007 9
Table 4: Global biotechnology market segmentation-geography, % share, 2007 10
Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008 17
Table 6: Revenue growth of global top 10 biotechnology companies, 2006-08 21
Table 7: Key financials of global top 10 biotechnology companies, FY2008 23
Table 8: Key industry specific ratios, FY2008 26
Table 9: Amgen-Financial and operational highlights, 2004-08 ($ million) 73
Table 10: Amgen-Key industry specific ratios, 2004-2008 75
Table 11: Genentech-Financial and operational highlights, 2004-08 ($ million) 76
Table 12: Genentech-Key industry specific ratios, 2004-08 78
Table 13: Gilead Sciences-Financial and operational highlights, 2004-08 ($ million) 79
Table 14: Gilead Sciences-Key industry specific ratios, 2004-08 81
Table 15: Part(A) UCB-Financial and operational highlights, 2004-08 ($ million) 82
Table 16: Part(B) UCB-Financial and operational highlights, 2004-08 ($ million) 83
Table 17: UCB-Key industry specific ratios, 2004-08 84
Table 18: Genzyme-Financial and operational highlights, 2004-08 ($ million) 85
Table 19: Genzyme-Key industry specific ratios, 2004-08 87
Table 20: Biogen Idec-Financial and operational highlights, 2004-08 ($ million) 88
Table 21: Biogen Idec-Key industry specific ratios, 2004-08 90
Table 22: CSL-Financial and operational highlights, 2004-08 ($ million) 91
Table 23: CSL-Key industry specific ratios, 2004-08 93
Table 24: Celgene- Financial and operational highlights, 2004-08 ($ million) 94
Table 25: Celgene-Key industry specific ratios, 2004-08 96
Table 26: Cephalon-Financial and operational highlights, 2004-2008 ($ million) 97
Table 27: Cephalon-Key industry specific ratios, 2004-08 99
Table 28: Actelion-Financial and operational highlights, 2004-08 ($ million) 100
Table 29: Actelion-Key industry specific ratios, 2004-08 102
List of Figures
Figure 1: Global biotechnology market, $ million, 2003-07 7
Figure 2: Global biotechnology market forecast, $ million, 2007-12 8
Figure 3: Global biotechnology market segmentation-product, % share, 2007 9
Figure 4: Global biotechnology market segmentation-geography, % share, 2007 10
Figure 5: Forces driving competition in the global biotechnology market 11
Figure 6: Drivers of buyer power in the global biotechnology market 12
Figure 7: Drivers of supplier power in the global biotechnology market 13
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market 14
Figure 9: Factors influencing the threat of substitutes in the global biotechnology market 15
Figure 10: Drivers of degree of rivalry in the global biotechnology market 16
Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008 18
Figure 12: Revenue growth of global top 10 biotechnology companies, 2006-08 22
Figure 13: Operating performance analysis, FY2008 24
Figure 14: Net profit analysis, FY2008 25
[Cerrar la tabla de contenidos]